查找临床试验
已按「重症肌无力」检索，对应国际通用词 myasthenia gravis
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 10:03，每 5 分钟自动同步Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
France
年龄 18 Years – 不限
Centre Hospitalier Universitaire de Nice
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
United States
年龄 18 Years – 85 Years
Aurinia Pharmaceuticals Inc.
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
United States、Australia、Belgium、Canada、China 等 12 国
年龄 18 Years – 不限
Janssen Research & Development, LLC
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
United States、Belgium、Germany、Greece、Italy 等 8 国
年龄 18 Years – 不限
argenx
Myasthenia Gravis Foundation of America Global MG Patient Registry
United States
年龄 18 Years – 不限
Myasthenia Gravis Foundation of America
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
United States、Austria、Belgium、Canada、France 等 12 国
年龄 2 Years – 18 Years
argenx
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Belgium
年龄 18 Years – 不限
Centre Hospitalier Universitaire de Liege
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Italy
年龄 18 Years – 不限
Alexion Pharmaceuticals, Inc.
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
United States、Italy、Poland、South Korea、United Kingdom
年龄 12 Years – 17 Years
UCB Biopharma SRL
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
United States、Austria、Belgium、Germany、Italy 等 6 国
年龄 18 Years – 不限
argenx
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
United States
年龄 18 Years – 不限
University of Colorado, Denver
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
United States、Argentina、Australia、Belgium、Bulgaria 等 12 国
年龄 18 Years – 不限
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany